Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat

Laboratory Investigation

Volumn 75, Issue 1, 1996, Pages 15-24

  Omori, Nobuhiko ^a   Evarts, Ritva P ^a   Omori, Masako ^a   Hu, Zongyi ^a   Marsden, Elizabeth R ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN RECEPTOR; LEUKEMIA INHIBITORY FACTOR; RECEPTOR SUBUNIT;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; LIVER CELL; LIVER REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIGENS, CD; BILE DUCTS; BLOTTING, NORTHERN; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; EPITHELIUM; GROWTH INHIBITORS; HEPATECTOMY; IN SITU HYBRIDIZATION; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LIVER; LIVER REGENERATION; LYMPHOKINES; MALE; MEMBRANE GLYCOPROTEINS; OROSOMUCOID; RATS; RATS, INBRED F344; RECEPTORS, CYTOKINE; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0029890897     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, and Diehl AM (1992). Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am J Physiol 263:G579-G585.
2. Baffet G, Braciak TA, Fletcher RG, Gauldie J, Fey GH, and Northemann W (1991). Autocrine activity of interleukin 6 by hepatoma cell lines. Mol Biol Med 8:141-156.
3. Baumann H and Gauldie J (1990). Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 7:147-159.
4. Baumann H and Gauldie J (1994). The acute phase response. Immunol Today 15:74-80.
5. Bisgaard HC, Parmelee DC, Dunsford HA, Sechi S, and Thorgeirsson SS (1993). Keratin 14 protein in cultured non-parenchymal rat hepatic epithelial cells: Characterization of keratin 14 and keratin 19 as antigens for the commonly used mouse monoclonal antibody OV-6. Mol Carcinog 7:60-66.
6. Brown MA, Metcalf D, and Gough NM (1994). Leukemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation. Cytokine 6:300-309.
7. Busam KJ, Bauer TM, Bayer J, Gerok W, and Decker K (1990). Interleukin-6 release by rat liver macrophages. J Hepatol 11:367-373.
8. DeFelici M and Pesce M (1994). Growth factors in mouse primordial germ cell migration and proliferation. Prog Growth Factor Res 5:135-143.
9. Dunsford HA and Sell S (1989). Production of monoclonal antibodies to preneoplastic liver cell populations induced by chemical carcinogens in rats and transplantable Morris hepatomas. Cancer Res 49:4887-4893.
10. Escary JL, Perreau J, Dumenil D, Ezine S, and Brulet P (1993). Leukemia inhibitory factor is necessary for maintenance of hematopoietic stem cells and thymocyte stimulation. Nature 363:361-364.
11. Evarts RP, Hu Z, Fujio K, Marsden ER, and Thorgeirsson SS (1993). Activation of hepatic stem cell compartment in the rat: Role of transforming growth factor α, hepatocyte growth factor, and acidic fibroblast growth factor. Cell Growth Differ 4:555-561.
12. Evarts RP, Nagy P, Nakatsukasa H, Marsden ER, and Thorgeirsson SS (1989). In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res 49:1541-1547.
13. Evarts RP, Nakatsukasa H, Marsden ER, Hu Z, and Thorgeirsson SS (1992). Expression of transforming growth factor-alpha in regenerating liver during hepatic differentiation. Mol Carcinog 5:25-31.
14. Fong Y, Helfgott DC, and Brennan MF (1993). Interleukin-6 blockade impedes recovery from experimental hepatectomy. Surg Forum 49:190-192.
15. Fort P, Marty L, Piechaczyk M, El Sabrouty S, Dani C, Jeanteur P, and Blanchard JM (1985). Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13:1431-1442.
16. Fujio K, Evarts RP, Hu Z, Marsden ER, and Thorgeirsson SS (1994). Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest 70:511-516.
17. Fujiok, K, Hu Z, Evarts RP, Marsden ER, Niu CH, and Thorgeirsson SS (1996). Coexpression of stem cell factor and c-kit in embryonic and adult liver. Exp Cell Res 224:243-250.
18. 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251-7255.
19. Gearing DP (1993). The leukemia inhibitory factor and its receptor. Adv Immunol 53:31-58.
20. Gearing DP, Gough NM, King JA, Hilton DJ, Nicola NA, Simpson RJ, Nice EC, Kelso A, and Metcalf D (1987). Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor (LIF). EMBO J 6:3995-4002.
21. 2 downregulates Kupffer cell production of IL-1 and IL-6 during hepatic regeneration. Am J Physiol 264:G601-G608.
22. Hilton DJ and Gough NM (1991). Leukemia inhibitory factor: A biological perspective. J Cell Biochem 46:21-26.
23. Hilton DJ, Nicola NA, and Metcalf D (1991a). Distribution and comparison of receptors for leukemia inhibitory factor on murine hematopoietic and hepatic cells. J Cell Physiol 146: 207-215.
24. Hilton DJ, Nicola NA, Waring PM, and Metcalf D. (1991b). Clearance and fate of leukemia inhibitory factor (LIF) after injection inito mice. J Cell Physiol 148:430-439.
25. 2. J Hepatol 21:543-550.
26. Kamohara H, Sakamoto K, Ishiko T, Mita S, Masuda Y, Abe T, and Ogawa M (1994). Human carcinoma cell lines produce biologically active leukemia inhibitory factor. Res Commun Mol Pathol Pharmacol 85:131-139.
27. Kishimoto T, Akira S, Narazaki M, and Taga T (1995). Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254.
28. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, and Koehler G (1994). Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342.
29. Kuma S, Inaba M, Ogata H, Inaba K, Okumura T, Saito K, yamamoto M, and Ikehara S (1990). Effect of human recombinant interleukin-6 on the proliferation of mouse hepatocytes in primary culture. Immunobiology 180:235-242.
30. Kurzrock R, Estrov Z, Wetzler M, Gutterman JU, and Talpaz M (1991). LIF: Not just a leukemia inhibitory factor. Endocrinol Rev 12:208-217.
31. Layton MJ, Cross BA, Metcalf D, Ward LD, Simpson RJ, and Nicola NA (1992). A major binding protein for leukemia inhibitory factor in normal mouse serum: Identification as a soluble form of the cellular receptor. Proc Natl Acad Sci USA 89:8616-8620.
32. Lotz M, Zuraw BL, Carson DA, Jirik FR (1989). Hepatocytes produce interleukin-6. Ann N Y Acad Sci 557:509-511.
33. Matsumoto K, Fuji H, Michalopoulos G, Fung JJ, and Demetris AJ (1994). Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: Interleukin-6, hepatocytes growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 20:376-382.
34. McMahon JB, Richards WL, del Campo AA, Song M, and Thorgeirsson SS (1986). Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res 46:4665-4671.
35. Nakamura T, Arakaki R, and Ichihara A (1988). Interleukin-1β is a potent growth inhibitor of adult rat hepatocytes in primary culture. Exp Cell Res 179:488-497.
36. Northemann W, Hattori M, Baffet G, Braciak TA, Fletcher RG, Abraham LJ, Gauldie J, Baumann M, and Fey GH (1990). Production of interleukin 6 by hepatoma cells. Mol Biol Med 7:273-285.
37. Ogawa K, Medline A, and Farber E (1979). Sequential analysis of hepatic carcinogenesis: The comparative architecture of preneoplastic, malignant, prenatal, postnatal and regenerating liver. Br J Cancer 40:782-790.
38. Okada K, Shimizu Y, Nambu S, Higuchi K, and Watanabe A (1994). Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line. J Gastroenterol Hepatol 9:462-467.
39. Paroli M, Carloni G, Alfani E, De Petrillo G, and Barnaba V (1993). Interleukin-6 production by human hepatoma lines is related to a low degree of cell differentiation. Res Virol 144:323-326.
40. Pesce M, Farrace MG, Piacentini M, Dolci S, and DeFelici M (1993). Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development 118:1089-1094.
41. Piquet-Pellorce C, Grey L, Mereau A, and Heath JK (1994). Are LIF and related cytokines functionally equivalent? Exp Cell Res 213:340-347.
42. Robertson M, Chambers I, Rathjen P, Nichols J, and Smith A (1993). Expression of alternative forms of differentiation inhibiting activity (DIA/LIF) during murine embryogenesis and neonatal and adult tissues. Dev Genet 14:165-173.
43. Saito M, Yoshida K, Hibi M, Taga T, and Kishimoto T (1992). Molecular cloning of murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J Immunol 12:4066-4071.
44. Smith AG and Hooper ML (1987). Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol 121:1-9.
45. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, and Abbondanzo SJ (1992). Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359:76-79.
46. Sui X, Tsuji K, Tanaka R, Tajima S, Muraoka K, Ebihara Y, Ikebuchi K, Yasukawa K, Taga T, Kishimoto T, and Nakahata T (1995). gp130 and c-kit signalings synergize for ex vivo expansion of human primitive hematopoietic progenitor cells. Proc Natl Acad Sci USA 92:2859-2863.
47. Thorgeirsson SS, Evarts RP, Fujio K, and Hu Z (1994). Cellular biology of the rat hepatic stem cell compartment. In: Skouteris GG, editor. Liver carcinogenesis: The molecular pathways. Berlin: Springer-Verlag, 129-145.
48. Tomida M, Yamamoto-Yamaguchi Y, and Hozumi M (1993). Pregnancy associated increase in mRNA for soluble D-factor/LIF receptor in mouse liver. FEBS Lett 334:193-197.
49. Tomida M, Yamamoto-Yamaguchi Y, and Hozumi M (1994). Three different cDNAs encoding mouse D-factor/LIF receptor. J Biochem 115:557-562.
50. von Schweinitz D, Hadam MR, Welte K, Mildenberger H, and Pietsch T (1993). Production of interleukin-1β and interleukin-6 in hepaoblastoma. Int J Cancer 53:728-734.
51. Wang Y, Nesbitt J, Fuentes NL, and Fuller GM (1992). Molecular cloning and characterization of the rat liver IL-6 signal transducing molecule, gp130. Genomics 14:666-672.
52. Ware CB, Holowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar SA, Gliniak BC, McKenna HJ, Papayannopoulou T, Thoma B, Cheng L, Donovan PJ, Peschon JJ, Bartlett PF, Willis CR, Wright BD, Carpenter MK, Davison BL, and Gearing DP (1995). Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121:1283-1299.
53. Waring PM, Waring LJ, Billington T, and Metcalf D (1995). Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc Natl Acad Sci USA 92:1337-1341.
54. Yamamori T (1991). Localization of cholinergic differentiation factor/leukemia inhibitory factor mRNA in the rat brain and peripheral tissues. Proc Natl Acad Sci USA 88:7298-7302.
55. Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N, and Kishimoto T (1996). Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci USA 93:407-411.